Non-Squamous Non-Small Cell Lung Cancer Active Not Recruiting Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02367781A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT02264990Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former SmokersTreatment
NCT02366143A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT01763671Paclitaxel-bevacizumab in Advanced Lung CancerTreatment